163.2. Symp. S35-2. Tue 16/07 09:30 - Amphithéâtre Havane
Sibson N. (1), Blamire A. (1), Perry H. (2), Gauldie J. (3), Styles P. (1) & Anthony D. C. (4).
(1) MRC Biochemical & Clinical MR Unit, Oxford, UK; (2) CNS Inflammation Group, Southampton, UK; (3) Dept. Pathology & Molecular Medicine, Hamilton, Canada; (4) Molecular Neuropathology Lab., Southampton, UK
- TNF-ALPHA REDUCES CEREBRAL PERFUSION AND COMPROMISES NEURONAL ENERGY METABOLISM.
163.3. Symp. S35-3. Tue 16/07 09:30 - Amphithéâtre Havane
Minghetti L.
Istituto Superiore di Sanità, Rome, Italy
- ANTI-INFLAMMATORY AND NEUROPROTECTIVE ACTIVITIES OF PROSTAGLANDIN E2.
163.4. Symp. S35-4. Tue 16/07 09:30 - Amphithéâtre Havane
Heneka M. T. (1), Landreth G. E. (2), Feinstein D. L. (3) & Klockgether T. (4)
(1) Neuroinflammation Res. Lab., Dept. Neurol., Bonn, Germany; (2) Dept. Neurosci., Case Western Reserve Univ., Cleveland, USA; (3) Dept. Neuroanesthesia Res., UIC, Chicago, USA; (4) Neuroinflammation Res. Lab., Dept. Neurol., Bonn Germany
- PPARGAMMA-MEDIATED ANTIINFLLAMMATORY MECHANISMS IN THE CNS.